Vixipin eye drops 1% 5% 5ml vial, 1pc

Composition

>1 ml of the drug contains: Active ingredient: Methylethylpyridinol Hydrochloride 10.0 MGM Auxiliary substances: Hydroxypropyl Betadex 20.00 mg Potassium Dihydrogen Phosphate 10.80 mg Sodium benzoate 2.00 mg Sodium hyaluronate 1.80 mg Sodium hydrophosphate dihydrate 0.36 mg Disodium edetate dihydrate (Trilon B) 0.20 mg Phosphoric acid solution 2 M to pH 4.0-5.0 Water for injection up to 1 ml

Pharmacological action

Pharmacotherapy group

An antioxidant remedy.

ATX Code: S01XA

Pharmacological properties

Pharmacodynamics

The drug reduces capillary permeability, strengthens the vascular wall, stabilizes the cell membrane, inhibits platelet aggregation, reduces blood clotting and viscosity, has anti-aggregation and antihypoxic effects.

Pharmacokinetics

The drug quickly penetrates the eye tissue, where it is deposited and metabolized. In the tissues of the eye, the concentration is higher than in the blood. 5 metabolites were found, represented by dealkylated and conjugated products of its transformation. It is metabolized in the liver. Metabolites are excreted by the kidneys. It binds to plasma proteins by an average of 42%.

Indications

-treatment and prevention of corneal inflammation and burns;

– treatment of hemorrhages in the anterior chamber of the eye;

– treatment and prevention of hemorrhages in the sclera in the elderly;

– thrombosis of the central retinal vein and its branches;

– treatment of complications of myopia;

– diabetic retinopathy.

Contraindications

Individual hypersensitivity to the components of the drug, pregnancy, breastfeeding, children under 18 years of age

Side effects

Possible burning sensation, itching, short-term conjunctival hyperemia, local allergic reactions. If any of the side effects listed in the instructions get worse, or you do not notice any other side effects that are not listed in the instructions, tell your doctor.

Interaction

The drug should not be mixed with other medicinal solutions.

How to take, course of use and dosage

The drug is instilled in the conjunctival cavity 1-2 drops 2-3 times a day. The duration of treatment depends on the course of the disease (usually 3 – 30 days) and is determined by the doctor. If there are indications and the drug is well tolerated, the course of treatment can be continued for up to 6 months or repeated 2-3 times a year.

Overdose

Cases of overdose of the drug are not described

Description

Transparent or almost transparent colorless or slightly colored liquid.

Special instructions

If it is necessary to simultaneously use other eye drops, the drug is instilled last, after complete absorption of the previous drug. (not earlier than in 15 minutes).

Influence on the ability to drive vehicles and mechanisms No data available.

Form of production

Eye drops 1%.0.5 ml per dropper tube made of low-density polyethylene or polypropylene. 5 dropper tubes each in a foil bag. 2,4 or 6 bags of foil film together with instructions for use in a pack of cardboard. 5 ml each in clear or brown glass vials, capped with medical attachments with or without protective caps, sealed with or without finger rest attachments. 1 bottle together with the instructions for use in a pack of cardboard.

Storage conditions

At a temperature not exceeding 25 ° C. Keep out of reach of children

Shelf

life is 2 years. After opening the bottle – 1 month. Do not use after the expiration date!

Active ingredient

Methylethylpyridinol

Conditions of release from pharmacies

By prescription

Dosage form

eye drops

Description

For adults as directed by your doctor

Indications

Diabetic retinopathy, Vascular eye diseases, Inflammatory eye diseases, Hemorrhages in the anterior chamber of the eye